How Budget 2026 Plans to Boost Ayurveda with Quality Control and Educational Expansion

India’s Union Budget 2026–27 has thrown a spotlight on traditional medicine and quality healthcare infrastructure, with a significant emphasis on expanding and modernising the Ayurveda sector. Among the key announcements is the government’s plan to establish three new All India Institutes of Ayurveda and to upgrade drug testing laboratories and AYUSH pharmacies nationwide, a move aimed at enhancing quality control, research, education, and global trust in traditional medicine systems.

Under the leadership of Finance Minister Nirmala Sitharaman, the Budget has sought to position Ayurveda as an integral component of India’s broader health ecosystem, combining heritage with modern standards. This comes as part of a wider strategy to support not just traditional medicine, but also allied health professionals, regional medical hubs, and preventive care services.

Three New Ayurveda Institutes: Centres of Educational and Clinical Excellence

One of the Budget’s flagship healthcare initiatives is the creation of three new All India Institutes of Ayurveda. These institutes are expected to serve as national centres of excellence, similar to how AIIMS functions for modern medicine. By expanding institutional capacity, the government aims to boost formal education, advanced research, and clinical practice in Ayurveda offering better training for doctors, therapists, researchers, and caregivers.

The institutes will not only enhance academic opportunities but also foster evidence-based Ayurvedic practice, helping integrate traditional systems with modern healthcare delivery. They also aim to produce a skilled workforce that can contribute to both domestic healthcare and international markets as demand for natural and preventive health solutions grows.

Modernising Drug Testing and Quality Control

A crucial part of the Budget’s vision is strengthening the drug testing infrastructure for Ayurvedic medicines. Historically, one challenge for the AYUSH sector has been ensuring consistent quality and global certification standards. By upgrading drug testing laboratories and AYUSH pharmacies, the government is taking a step toward improved quality control, reducing the prevalence of substandard products, and enhancing public trust in traditional medicines.

Improved testing and certification systems will also help Ayurveda products become more competitive in international markets, supporting exports and contributing to economic growth. Industry experts believe that stronger infrastructure and regulation can help bridge gaps in evidence, safety, and compliance, a factor critical for wider acceptance.

Broader Healthcare and Employment Gains

The Budget’s focus on Ayurveda is part of a larger healthcare expansion strategy. Alongside new institutes and lab upgrades, the government plans to develop regional medical tourism hubs and invest in allied health disciplines to train professionals in areas such as optometry, anaesthesia, and behavioural health. These measures aim to strengthen the healthcare system while creating new employment opportunities for youth and women across the country.

The government has also pledged support for the World Health Organization’s Global Centre for Traditional Medicine in Jamnagar, Gujarat, further positioning India as a global leader in traditional and integrative medicine.

Looking Ahead: Traditional Medicine with Global Standards

Budget 2026’s emphasis on Ayurveda and drug testing labs reflects a deliberate effort to modernise traditional healthcare while maintaining its core principles. By combining rigorous quality control with institutional expansion and workforce development, India is aiming to transform Ayurveda into a credible, globally recognised component of its healthcare ecosystem.